Physician profile
Patrick Wayne Kutas
NPI 1780719088
$2,185.45
in general payments reported to CMS, 2019-2025
10 companies · $405 in 2025
The $405 reported for 2025 was more than what 88% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $104 · 2021: $140 · 2022: $350 · 2023: $516 · 2024: $558 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729 · Gift: $525 · Education: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.70 |
| Gift | $525.17 |
| Education | $225.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $979.86 | 2021-2023 | Opalescence |
| Zimvie INC. | $396.61 | 2024-2025 | |
| Align Technology, INC. | $335.33 | 2020-2025 | Invisalign |
| Dentsply Sirona INC | $204.73 | 2019-2025 | Implant Dentistry, Ossix Plus |
| Straumann USA LLC | $143.28 | 2024-2025 | |
| Henry Schein, INC. | $73.33 | 2019 | |
| Solventum Corporation | $16.79 | 2024 | Clinpro 5000, 3m Scotchbond, Filtek |
| Gc America INC. | $14.80 | 2021 | |
| National Dentex LLC | $12.50 | 2021 | |
| Voco America INC. | $8.22 | 2025 | Meron Plus Qm, Futurabond U, Structur Premium |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Kutas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.